Zobrazeno 1 - 10
of 122
pro vyhledávání: '"K, Chouahnia"'
Autor:
B. Duchemann, A. Paix, L. Matton, M. Didier, D. Radu, M. Kambouchner, O. Freynet, K. Chouahnia, P.-Y. Brillet, H. Nunes
Publikováno v:
Revue des Maladies Respiratoires Actualités. 14:2S378-2S385
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e67935888351b7a2d3d15a3f934fe2
https://doi.org/10.1016/s1877-1203(22)00142-2
https://doi.org/10.1016/s1877-1203(22)00142-2
Autor:
C. Chouaid, E. Pichon, M. Wislez, P. Giraud, W. Hilgers, C. Daniel, M. Pérol, K. Chouahnia, S. Ano, M. Giaj Levra, C. Correia Da Silva, L. Falchero
Publikováno v:
Revue des Maladies Respiratoires Actualités. 14:60-61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d57f4abfffaa3434538a7ecc3abb175
https://doi.org/10.1016/j.rmra.2021.11.550
https://doi.org/10.1016/j.rmra.2021.11.550
Publikováno v:
Revue Neurologique. 175:95-97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3464b928f15ce3dfc3737dca4d518f9
https://doi.org/10.1016/j.neurol.2018.03.013
https://doi.org/10.1016/j.neurol.2018.03.013
Autor:
Thierry Landre, K. Chouahnia, Cherifa Taleb, Gaetan Des Guetz, Stéphane Culine, Virginie Fossey-Diaz
Publikováno v:
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Elsevier, 2019, 17, pp.e806-e813. ⟨10.1016/j.clgc.2019.05.001⟩
Clinical Genitourinary Cancer, Elsevier, 2019, 17, pp.e806-e813. ⟨10.1016/j.clgc.2019.05.001⟩
Background Results from large randomized controlled trials combining docetaxel, abiraterone, celecoxib, or bisphosphonates with androgen deprivation therapy (ADT) in hormone-sensitive prostate cancer have emerged. However, in our knowledge, few data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e66a74bd0ee8e791ee2f29b9c80b79a
https://hal.archives-ouvertes.fr/hal-03488039
https://hal.archives-ouvertes.fr/hal-03488039
Autor:
Morgane Didier, Boris Duchemann, K. Chouahnia, Hilario Nunes, L. Zelek, Olivia Freynet, Pierre-Yves Brillet, Yurdagul Uzunhan, M.-C. Pailler, Marianne Kambouchner
Publikováno v:
Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36, pp.209-213. ⟨10.1016/j.rmr.2018.11.001⟩
Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36, pp.209-213. ⟨10.1016/j.rmr.2018.11.001⟩
Anti-PD1 immunotherapies have become an essential treatment for bronchial cancer. According to published studies, PD1 and PD-L1 inhibitors have a better toxicity profile than chemotherapy. Nevertheless, some immune related toxicities can be potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3470a15cb15acf0f082674d4bd62ac5
https://hal.archives-ouvertes.fr/hal-03486117/document
https://hal.archives-ouvertes.fr/hal-03486117/document
Autor:
B, Duchemann, M, Didier, M-C, Pailler, P-Y, Brillet, M, Kambouchner, Y, Uzunhan, O, Freynet, K, Chouahnia, L, Zelek, H, Nunes
Publikováno v:
Revue des maladies respiratoires. 36(2)
Anti-PD1 immunotherapies have become an essential treatment for bronchial cancer. According to published studies, PD1 and PD-L1 inhibitors have a better toxicity profile than chemotherapy. Nevertheless, some immune related toxicities can be potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff014578c1365547688d1c8709d007fa
https://pubmed.ncbi.nlm.nih.gov/30686563
https://pubmed.ncbi.nlm.nih.gov/30686563
Autor:
Laurence Vanlemmens, K. Chouahnia, J.M. Descotes, Florence Joly, Florian Scotté, Sarah Dauchy, C. Brami, C. Delcambre, Jean-Philippe Spano, G. Lepeu, T. Bouillet, Laurent Zelek, A. Marre, Laure Copel, X. Bigard
Publikováno v:
Critical Reviews in Oncology/Hematology. 94:74-86
This overview reports published data about the interaction between physical activity and sport during and after cancer on one hand and improvement in psychological parameters, survival and biological mechanisms underlying this effect on the other han
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1812d5acde43d0abe448b03a91c1887a
https://doi.org/10.1016/j.critrevonc.2014.12.012
https://doi.org/10.1016/j.critrevonc.2014.12.012
Autor:
Hilario Nunes, Morgane Didier, L. Zelek, K. Chouahnia, B. Duchemann, Yurdagul Uzunhan, M.-C. Pailler
Publikováno v:
Revue des Maladies Respiratoires. 35:A115-A116
Introduction Bien que les inhibiteurs de PD1 et PDL1 aient un meilleur profil de tolerance que la chimiotherapie, ils peuvent induire des manifestations inflammatoires ou auto-immunes dont des pneumopathies interstitielles diffuses (PID) parfois seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36acd4e1dcd13203c9ce6da4ba4f9f76
https://doi.org/10.1016/j.rmr.2017.10.252
https://doi.org/10.1016/j.rmr.2017.10.252
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.